Status:
UNKNOWN
Dual Hypothermic Oxygenated Machine Perfusion in Liver Transplantation Using Allografts From Donors After Brain Death
Lead Sponsor:
Medical University of Warsaw
Collaborating Sponsors:
National Science Centre, Poland
Conditions:
Liver Cirrhosis
Liver Tumor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This will be a randomized study on the effects of hypothermic oxygenated machine perfusion in patients undergoing liver transplantations from donors after brain death with allocation of patients to ei...
Detailed Description
This will be a parallel, randomized controlled study on the effects of end-ischemic hypothermic oxygenated machine perfusion in liver transplantations from donors after brain death. Patients will be r...
Eligibility Criteria
Inclusion
- age \>18 years
- deceased-donor liver transplantation
- provision of informed consent
Exclusion
- donation after cardiac death
- either reduced or split graft
Key Trial Info
Start Date :
April 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04812054
Start Date
April 5 2021
End Date
April 1 2024
Last Update
April 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of General, Transplant and Liver Surgery, Medical University of Warsaw
Warsaw, Masovian Voivodeship, Poland, 02-097